HaiJin 海津 Meng 孟

首席医学官 Chief Medical Officer @ NRT

About

hmeng2018@163.com

Country

China

City

Chaoyang District

Industry

Pharmaceuticals

Skill

Clinical Research, Molecular Biology, Biochemistry, Pharmaceutical Industry, Cell Biology, Clinical Trials, NDA application and panel meeting, Health Authority communication, Genetic research, Phase I, Phase II, Phase III, Phase IV design, Animal disease modeling, Medical Affairs, Biomarker Discovery, People Management, People Development, PD-1/PD-L1, Oncology research

Experience

首席医学官 Chief Medical Officer

NRT

2026-1 - Present · 9 mos

创新医药临床研发

首席医学官 Chief Medical Officer

优锐医药科技(上海)有限公司 Nuance Pharma （Shanghai）Co. Ltd.

2021-6 - 2025-7 · 4 yrs 2 mos

首席科学官（中国）Chief Scientific Officer （China）

上药博康生物医药有限公司 SPH-Biocad（HK）

2020-8 - 2021-6 · 11 mos

中国北京市朝阳区

1) Lead R&D function for PhI-III study design，operation and registration. 2) Establish R&D team. 3) Support business development and pipeline management.

首席医学官，副总裁 Chief Medical Officer，VP

Harbin Gloria Pharmaceuticals Co., Ltd.

2017-12 - 2020-7 · 2 yrs 8 mos

北京

Lead R&D function (Medical，Operation and Regulatory). Design and execute clinical trials focusing on Oncology IO area.

Head of China Early Clinical Development

Bristol Myers Squibb

2016-9 - 2017-11 · 1 yr 3 mos

Lead academic collaboration for drug discovery; Responsible for China early phase clinical study, biomarker strategy development and implementation, for across many therapeutic areas (including oncology, cardiovascular diseases, etc.).

Head of Clinical Research CV Disease Area

Bristol Myers Squibb

2015-9 - 2016-9 · 1 yr 1 mo

Phase II design and implementatin, Phase III study reporting, NDA submission and HA interaction for cardiovascular (CV) disease area.

Sr. Medical Manager – Strategic Alliance

Pfizer

2007-8 - 2013-8 · 6 yrs 1 mo

Beijing City, China

Working with MoH for China CV Turning Point program. Develop and implement medical strategy in support of product lifecycle. Academic colllaboration.

Postdoctoral Researcher

UCLA

2003-6 - 2007-1 · 3 yrs 8 mos

Los Angeles

Genetic research for atherosclerosis, diabetes and Myocardial Infarction. Recipient of American Heart Association (AHA) Post-doc research grant (2004-2006). Recipient of 2006 AHA Atherosclerosis Thrombosis and Vascular Biology (ATVB)Young Investigator Award.